Muņoz, A E <br/><br/>
Interferon-alpha 2b combined with daily ketoprofen administration improves virological response in chronic hepatitis C: a prospective and randomised trial.  [electronic resource] 

 -  Gut  Mar 2000 
 - 427-31 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0017-5749 
<br/><br/><label>Standard No.: </label>10.1136/gut.46.3.427  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Antiviral Agents--administration & dosage<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Ketoprofen--administration & dosage<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Recombinant Proteins